1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE
Compound with spectra: 1 NMR
![1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE](/api/compound/IZwLVhUkscF.png?ph=true&h=300&w=458 "1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE")
| SpectraBase Compound ID | IZwLVhUkscF |
|---|---|
| InChI | InChI=1S/C29H32ClN5O/c1-35(33-28(36)14-8-5-11-22-9-3-2-4-10-22)19-17-34(18-20-35)29-24-12-6-7-13-25(24)31-26-16-15-23(30)21-27(26)32-29/h2-4,6-7,9-10,12-13,15-16,21,31H,5,8,11,14,17-20H2,1H3 |
| InChIKey | UJXKEJGMGODALM-UHFFFAOYSA-N |
| Mol Weight | 502.1 g/mol |
| Molecular Formula | C29H32ClN5O |
| Exact Mass | 501.229538 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-2-(PHENYL)-ACETIMIDE
Clozapine-M (7 OH)
Clozapine-M (6 OH)
Clozapine ME
(12-N-Methyl)-11-(o-methylaniline)-5H-dibenzo[b,e][1,4]diazepines
(12-N-Methyl)-11-(o-bromoaniline)-5H-dibenzo[b,e][1,4]diazepines
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS Acting Agents. II Design, Synthesis, and Receptor Binding of 4′-Arylalkyl Aminimide Analogues of Clozapine as Prospective Novel Antipsychotics | Australian Journal of Chemistry | 2008 |